Humanwell Healthcare Financials
| 600079 Stock | 23.80 0.32 1.36% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 3.8 B | 3.6 B |
|
|
Humanwell | Select Account or Indicator |
Understanding current and past Humanwell Healthcare Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Humanwell Healthcare's financial statements are interrelated, with each one affecting the others. For example, an increase in Humanwell Healthcare's assets may result in an increase in income on the income statement.
Please note, the presentation of Humanwell Healthcare's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Humanwell Healthcare's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Humanwell Healthcare's management manipulating its earnings.
Humanwell Healthcare Stock Summary
Humanwell Healthcare competes with China State, Poly Real, China Vanke, China Merchants, and Huafa Industrial. Humanwell Healthcare is entity of China. It is traded as Stock on SHG exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | China Stock View All |
| Exchange | Shanghai Stock Exchange |
| ISIN | CNE000000QW6 |
| Business Address | No 666, Gaoxin |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.humanwell.com.cn |
| Phone | 86 27 8759 7232 |
You should never invest in Humanwell Healthcare without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Humanwell Stock, because this is throwing your money away. Analyzing the key information contained in Humanwell Healthcare's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Humanwell Healthcare Key Financial Ratios
Humanwell Healthcare's financial ratios allow both analysts and investors to convert raw data from Humanwell Healthcare's financial statements into concise, actionable information that can be used to evaluate the performance of Humanwell Healthcare over time and compare it to other companies across industries.| Revenue | 24.52 B | ||||
| Gross Profit | 8.77 B | ||||
| EBITDA | 4.23 B | ||||
| Net Income | 2.13 B | ||||
| Total Asset | 36.2 B |
Humanwell Healthcare Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 35.0B | 31.6B | 34.5B | 36.0B | 36.2B | 38.0B | |
| Other Current Liab | 1.9B | 1.6B | 2.3B | 377.7M | 44.7M | 42.5M | |
| Retained Earnings | 3.5B | 4.4B | 5.5B | 7.3B | 9.4B | 9.8B | |
| Accounts Payable | 3.3B | 2.4B | 2.7B | 3.4B | 3.2B | 3.4B | |
| Cash | 3.4B | 5.4B | 5.1B | 5.2B | 4.1B | 4.3B | |
| Other Assets | 2.0B | 2.1B | 1.6B | 2.2B | 2.5B | 2.6B | |
| Long Term Debt | 4.3B | 5.1B | 3.2B | 1.9B | 1.7B | 1.6B | |
| Net Receivables | 8.8B | 5.9B | 6.8B | 7.5B | 8.1B | 8.5B | |
| Inventory | 3.4B | 2.7B | 3.1B | 3.4B | 3.6B | 3.8B | |
| Other Current Assets | 1.0B | 799.1M | 833.8M | 333.2M | 182.1M | 173.0M | |
| Total Liab | 21.0B | 18.7B | 18.9B | 18.1B | 16.1B | 8.5B | |
| Intangible Assets | 2.9B | 1.8B | 2.5B | 2.8B | 2.6B | 2.7B | |
| Other Liab | 820.8M | 929.3M | 702.6M | 841.0M | 967.1M | 1.0B | |
| Good Will | 3.8B | 972.3M | 929.3M | 974.1M | 948.2M | 900.8M | |
| Net Tangible Assets | 4.3B | 3.9B | 8.0B | 10.1B | 11.6B | 6.2B | |
| Short Long Term Debt | 6.9B | 7.3B | 6.9B | 6.6B | 6.7B | 5.9B | |
| Total Current Assets | 17.3B | 17.0B | 18.1B | 19.4B | 19.6B | 17.7B | |
| Net Debt | 7.6B | 7.0B | 4.9B | 3.3B | 4.3B | 4.3B | |
| Net Invested Capital | 21.1B | 23.1B | 23.2B | 23.5B | 25.4B | 25.0B | |
| Net Working Capital | 1.4B | 4.1B | 3.2B | 4.3B | 6.4B | 3.4B |
Humanwell Healthcare Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 851.6M | 785.3M | 556.9M | 476.6M | 354.1M | 371.8M | |
| Total Revenue | 21.8B | 20.4B | 20.4B | 22.3B | 24.5B | 25.8B | |
| Operating Income | 1.9B | 2.9B | 2.7B | 2.9B | 3.6B | 3.8B | |
| Cost Of Revenue | 13.2B | 11.7B | 11.6B | 12.6B | 13.3B | 14.0B | |
| Income Before Tax | 1.8B | 2.1B | 2.2B | 3.4B | 3.4B | 3.6B | |
| Net Income | 842.5M | 1.1B | 1.4B | 2.5B | 2.1B | 2.2B | |
| Income Tax Expense | 483.9M | 428.0M | 385.1M | 354.8M | 408.0M | 428.4M | |
| Minority Interest | 3.8B | 2.2B | (456.4M) | (587.2M) | (680.8M) | (646.7M) | |
| Research Development | 591.2M | 765.0M | 804.8M | 966.9M | 1.5B | 1.5B | |
| Gross Profit | 8.6B | 8.6B | 8.8B | 9.7B | 11.2B | 8.4B | |
| Ebit | 1.8B | 2.5B | 2.7B | 2.4B | 2.7B | 2.2B | |
| Tax Provision | 428.0M | 387.0M | 353.5M | 354.8M | 568.6M | 479.7M | |
| Net Interest Income | (877.8M) | (769.7M) | (520.6M) | (360.6M) | (350.5M) | (368.0M) | |
| Interest Income | 56.2M | 49.8M | 58.4M | 143.2M | 58.8M | 75.1M | |
| Ebitda | 3.2B | 3.5B | 3.4B | 4.7B | 5.3B | 3.4B |
Humanwell Healthcare Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Humanwell Healthcare. It measures of how well Humanwell is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Humanwell Healthcare brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Humanwell had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Humanwell Healthcare has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Dividends Paid | 974.1M | 709.9M | 665.6M | 612.9M | 587.7M | 358.5M | |
| Capital Expenditures | 809.6M | 1.1B | 1.7B | 3.1B | 2.0B | 2.1B | |
| Net Income | 842.5M | 1.1B | 1.3B | 2.5B | 2.1B | 2.2B | |
| Change To Inventory | (204.6M) | (93.7M) | (486.2M) | (360.8M) | (200.4M) | (210.4M) | |
| Investments | 2.9M | (494.4M) | 202.5M | 1.2B | (1.2B) | (1.2B) | |
| Change In Cash | (835.7M) | 2.5B | (180.4M) | (528.6M) | (1.3B) | (1.3B) | |
| Net Borrowings | 458.8M | (1.8B) | 1.6B | (1.4B) | (1.2B) | (1.2B) | |
| Depreciation | 577.6M | 680.7M | 606.9M | 748.1M | 812.0M | 631.3M | |
| Change To Netincome | 3.9B | 1.3B | 1.5B | 893.9M | 1.0B | 1.1B | |
| End Period Cash Flow | 2.4B | 5.0B | 4.8B | 4.3B | 3.0B | 4.0B | |
| Free Cash Flow | 1.2B | 912.6M | 317.8M | (672.3M) | 8.9M | 9.4M | |
| Other Non Cash Items | 875.5M | 920.1M | 597.1M | 334.3M | 336.6M | 487.7M |
Humanwell Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Humanwell Healthcare's current stock value. Our valuation model uses many indicators to compare Humanwell Healthcare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Humanwell Healthcare competition to find correlations between indicators driving Humanwell Healthcare's intrinsic value. More Info.Humanwell Healthcare Group is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.46 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Humanwell Healthcare Group is roughly 2.16 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Humanwell Healthcare by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Humanwell Healthcare's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Humanwell Healthcare Systematic Risk
Humanwell Healthcare's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Humanwell Healthcare volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Humanwell Healthcare correlated with the market. If Beta is less than 0 Humanwell Healthcare generally moves in the opposite direction as compared to the market. If Humanwell Healthcare Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Humanwell Healthcare is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Humanwell Healthcare is generally in the same direction as the market. If Beta > 1 Humanwell Healthcare moves generally in the same direction as, but more than the movement of the benchmark.
Humanwell Healthcare Group Total Assets Over Time
Humanwell Healthcare Thematic Clasifications
Humanwell Healthcare Group is part of Health Management investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Healthcare providers, hospitals. Major hospitals and healthcare providers
This theme covers Healthcare providers, hospitals. Major hospitals and healthcare providers. Get More Thematic Ideas
| Health Management | View |
Humanwell Healthcare November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Humanwell Healthcare help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Humanwell Healthcare Group. We use our internally-developed statistical techniques to arrive at the intrinsic value of Humanwell Healthcare Group based on widely used predictive technical indicators. In general, we focus on analyzing Humanwell Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Humanwell Healthcare's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.44 | |||
| Information Ratio | 0.0652 | |||
| Maximum Drawdown | 13.2 | |||
| Value At Risk | (3.88) | |||
| Potential Upside | 6.09 |
Complementary Tools for Humanwell Stock analysis
When running Humanwell Healthcare's price analysis, check to measure Humanwell Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humanwell Healthcare is operating at the current time. Most of Humanwell Healthcare's value examination focuses on studying past and present price action to predict the probability of Humanwell Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humanwell Healthcare's price. Additionally, you may evaluate how the addition of Humanwell Healthcare to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets |